Balanced news tone
News Sentiment
SCNX sentiment intelligence
Scienture Holdings, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
84/100 classification confidence.
directly relevant articles
high-authority source matches
+7.6% over one week, -2.1% over four weeks, trend inactive, and below fair value.
Scienture Holdings Company Profile & Introduction
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 09 Jun 2026 12:05
- Source
- GlobeNewswire
EXCLUSIVE: Scienture Expands Coverage For Opioid Overdose Treatment Ahead Of Commercial Launch
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 09 Jun 2026 11:46
- Source
- Benzinga
SCIENTURE to Present at The Small Cap Showcase & WTR Insights on June 9, 2026, in NYC
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 12:00
- Source
- ACCESS Newswire
Scienture Secures US Patent Protection for Rezenopy Through 2041
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 13:15
- Source
- MT Newswires
SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 12:05
- Source
- GlobeNewswire
SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion
- Tone
- Positive 79/100
- Event
- Earnings
- Published
- 18 May 2026 12:38
- Source
- GlobeNewswire
Scienture Holdings: Q1 Earnings Snapshot
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 May 2026 20:58
- Source
- Associated Press
Scienture Holdings, Inc. Receives Additional 180-Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- Quiver Quantitative
Scienture Holdings 10-K: $0.43M Revenue, $(2.70) EPS — ARBLI™ Launch Drives Growth
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 30 Mar 2026 07:00
- Source
- TradingView
Scienture (NASDAQ: SCNX) begins Arbli sales; $256M losartan market, 2,500 institutions
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Oct 2025 07:00
- Source
- Stock Titan
Scienture (SCNX) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Sep 2024 14:01
- Source
- MarketBeat